THE DEVELOPMENT OF ALGINATE-BASED MATRICES LOADED WITH RIFAMPICIN FOR WOUND HEALING
Abstract
The proposed study aims to develop polymeric systems based on alginate and N-vinylcaprolactam (NVCL) coated with poly(D,L-lactide-co-glycolide) (PLGA) as vehicles for Rifampicin (RIF) as active substance. Rifampicin is an agent used for tuberculosis treatment, but the present study proposes to be used for wound healing. The proposed topic is a complex study comprising a lot of data; herein information on Rifampicin loaded matrix and its antimicrobial activity against the main strains of the following bacteria: S. aureus, MRSA, E. coli, P. aeruginosa. Materials and methods: Alginate and NVCL were used as main materials for polymer preparation then coated with PLGA; the polymeric matrix was loaded with Rifampicin as active substance. The preparation of polymer consisted of various steps such as polymerization technique, water in oil in water emulsification and then matrix lyophilization for characterization in solid state. Chromatography was used to indicate the presence of the drug (TLC) and then HPLC was used to quantify the amount of it. The antimicrobial activity was tested by culturing the tested substances against some bacteria e.g. S. aureus, MRSA, E. coli, P. aeruginosa. Results: The tested matrix showed positive results in terms of drug loading and antimicrobial activity and will be further investigated for IC50 and cytotoxicity. Conclusions: Based on the obtained results, the proposed rifampicin-loaded alginate-based matrix shows potential in wound treatment, including surgical wound care.
References
2. Kozanoǧlu S, Özdemir T, Usanmaz A. Polymerization of N-Vinylcaprolactam and Characterization of Poly(N-Vinylcaprolactam). J Macromol Sci A 2011; 48: 467-477.
3. Marsili L, Dal Bo M, Eisele G, Donati I, Berti F, Toffoli G. Characterization of Thermoresponsive Poly-N-Vinylcaprolactam Polymers for Biological Applications. Polymers 2021;13: 2639 / doi: 10.3390/polym13162639
4. Chellini PR, Lages EB, Franco PH, Nogueira FH, César IC, Pianetti GA. Development and Validation of an HPLC Method for Simultaneous Determination of Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol Hydrochloride in Pharmaceutical Formulations. J AOAC Int 2015; 98(5): 1234-1239 / doi: 10.5740/jaoacint.14-237
5. Matuschek E, Brown DF, Kahlmeter G. Development of the EUCAST Disk Diffusion Antimicrobial Susceptibility Testing Method and its Implementation in Routine Microbiology Laboratories. Clin Microbiol Infect 2014; 20(4): O255-266 / doi: 10.1111/1469-0691.12373.
6. Kozanoǧlu S, Özdemir T, Usanmaz A. Polymerization of N-Vinylcaprolactam and Characterization of Poly(N-Vinylcaprolactam), Journal of Macromolecular Science, Part A 2011; 48: 6, 467-477 / doi: 10.1080/10601325.2011.573350
7. Abdelwahab H, Martin Del Campo JS, Dai Y, Adly C, El-Sohaimy S, Sobrado P. Mechanism of Rifampicin Inactivation in Nocardia farcinica. PloS ONE 2016; 11(10): e0162578 / doi: 10.1371 /journal.pone.0162578
8. Ashkenazi I, Thomas J, Lawrence KW, Rozell JC, Lajam CM, Schwarzkopf R. Positive preoperative colonization with Methicillin Resistant Staphylococcus Aureus is associated with inferior postoperative outcomes in patients undergoing total joint arthroplasty. J Arthroplasty 2023; 38(6): 1016-1023 / doi: 10.1016/j.arth.2023.02.065
9. Celebi D, Aydın E, Rakici E, Baser S, Celebi O, Taghizadehghalehjoughi A. Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains. Mol Biol Rep 2023; 31 / doi: 10.1007/s11033-023-08532-z.
10. Cao P, Fleming D, Moustafa DA, et al. A Pseudomonas aeruginosa small RNA regulates chronic and acute infection. Nature 2023; 24 / doi: 10.1038/s41586-023-06111-7.
11. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_13.0_Breakpoint_Tables.pdf
Additional Files
Published
Issue
Section
License
COPYRIGHT
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.
COPYRIGHT TRANSFER FORM FOR
REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /
THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI
We, the undersigned authors of the manuscript entitled
_____________________________________________________________________________________
_____________________________________________________________________________________
warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.
- we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
- the manuscript does not break the intellectual property rights of any other person.
- we have read the submitted version of the manuscript and we are fully responsible for the content.
Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):
- ______________________________/_________________________
- ______________________________/_________________________
- ______________________________/_________________________
N.B. All the authors must sign this form